Liposomes as immunological adjuvants: antigen incorporation studies, Vaccine, vol.5, issue.2, pp.145-151, 1987. ,
DOI : 10.1016/0264-410X(87)90063-6
Liposomes and ISCOMS as vaccine formulations, Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, vol.1241, issue.2, pp.117-138, 1995. ,
DOI : 10.1016/0304-4157(95)00002-9
Lipid based particulate formulations for the delivery of antigen, Immunology and Cell Biology, vol.45, issue.2, pp.97-105, 2005. ,
DOI : 10.1016/S0169-409X(98)00013-1
Immunoadjuvant action of liposomes: comparison with other adjuvants, Immunology Letters, vol.20, issue.3, pp.237-240, 1989. ,
DOI : 10.1016/0165-2478(89)90086-2
The Regulation of Immunity to Leishmania Major, Annual Review of Immunology, vol.13, issue.1, pp.151-177, 1995. ,
DOI : 10.1146/annurev.iy.13.040195.001055
T-cell and cytokine responses in leishmaniasis, Current Opinion in Immunology, vol.5, issue.4, pp.524-531, 1993. ,
DOI : 10.1016/0952-7915(93)90033-O
The promastigote surface protease of leishmania, Parasitology Today, vol.3, issue.5, pp.151-153, 1987. ,
DOI : 10.1016/0169-4758(87)90199-2
Leishmania major: Production of recombinant gp63, its antigenicity and immunogenicity in mice, Experimental Parasitology, vol.70, issue.4, pp.427-435, 1990. ,
DOI : 10.1016/0014-4894(90)90127-X
gp63 in Stable Cationic Liposomes Confers Sustained Vaccine Immunity to Susceptible BALB/c Mice Infected with Leishmania donovani, Infection and Immunity, vol.76, issue.3, pp.1003-1015, 2008. ,
DOI : 10.1128/IAI.00611-07
Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice, Vaccine, vol.24, issue.29-30, pp.5708-5717, 2006. ,
DOI : 10.1016/j.vaccine.2006.04.062
Leishmania major: Immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes, Experimental Parasitology, vol.115, issue.2, pp.127-134, 2007. ,
DOI : 10.1016/j.exppara.2006.07.002
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice, Parasite Immunology, vol.118, issue.5, pp.545-555, 1985. ,
DOI : 10.1111/j.1600-065X.1982.tb00378.x
The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome, Vaccine, vol.25, issue.32, pp.6107-6117, 2007. ,
DOI : 10.1016/j.vaccine.2007.05.009
Molecular cloning of the major surface antigen of leishmania, Journal of Experimental Medicine, vol.167, issue.2, pp.724-729, 1988. ,
DOI : 10.1084/jem.167.2.724
Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes, Bio/Technology, vol.71, issue.11, pp.979-984, 1984. ,
DOI : 10.1016/0005-2736(79)90085-3
Infection and the Implications for Vaccine Development, Annals of the New York Academy of Sciences, vol.194, issue.1, pp.267-272, 2004. ,
DOI : 10.1196/annals.1307.041
Leishmania vaccines: progress and problems, Parasitology, vol.170, issue.S2, pp.87-112, 2006. ,
DOI : 10.1017/S0031182006001831
Immunological adjuvants: a role for liposomes, Immunology Today, vol.11, pp.89-97, 1990. ,
DOI : 10.1016/0167-5699(90)90034-7
Recent advances with liposomes as pharmaceutical carriers, Nature Reviews Drug Discovery, vol.103, issue.2, pp.145-160, 2005. ,
DOI : 10.1081/LPR-120017488
Liposomes to target the lymphatics by subcutaneous administration, Advanced Drug Delivery Reviews, vol.50, issue.1-2, pp.143-156, 2001. ,
DOI : 10.1016/S0169-409X(01)00154-5
Antigen Delivery System: Immunological and Technological Issues, 1997. ,
INFLUENCE OF PHOSPHOLIPID COMPOSITION ON THE ADJUVANTICITY AND PROTECTIVE EFFICACY OF LIPOSOME-ENCAPSULATED LEISHMANIA DONOVANI ANTIGENS, Journal of Parasitology, vol.91, issue.2, pp.269-274, 2005. ,
DOI : 10.1645/GE-356R1